The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
The Russian National Research Medical University named after N.I. Pirogov

Frigo N.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Negasheva E.S.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Gushchin A.E.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Dolya O.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
Peoples’ Friendship University of Russia

Kitaeva N.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Dmitriev G.A.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
Gabrichevsky Institute Of Epidemiology And Microbiology

Mardanly S.G.

CJSC ECOlab

Golousenko I.Yu.

Russian University of Medicine

Epidemiology of M. genitalium infection. What is known?

Authors:

Potekaev N.N., Frigo N.V., Negasheva E.S., Gushchin A.E., Dolya O.V., Kitaeva N.V., Dmitriev G.A., Mardanly S.G., Golousenko I.Yu.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2025;24(2): 143‑152

DOI: 10.17116/klinderma202524021143

Read: 408 times

Buy for 300₽
Contact the author
Table of contents

EPIDEMIOLOGY OF M. GENITALIUM INFECTION. WHAT IS KNOWN?
EPIDEMIOLOGY OF M. GENITALIUM INFECTION. WHAT IS KNOWN?

To cite this article:

Potekaev NN, Frigo NV, Negasheva ES, et al. . Epidemiology of M. genitalium infection. What is known? Russian Journal of Clinical Dermatology and Venereology. 2025;24(2):143‑152. (In Russ.)
https://doi.org/10.17116/klinderma202524021143

Подписка 2025-2 (Russian Journal of Clinical Dermatology and Venereology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Extragenital forms of sexually transmitted infe­ctions in patients of dermatovenereological institutions in Moscow. Causative agents, features of clinical course, risk factors. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(4):384-391
Risk factors for severe novel coro­navirus infe­ction SARS-CoV-2 in women during pregnancy. Russian Journal of Human Reproduction. 2024;(3):57-64
Medi­cal and biological risk factors for the deve­lopment of pre-eclampsia of variable seve­rity in pregnant women with chro­nic arte­rial hype­rtension. Russian Journal of Human Reproduction. 2024;(3):77-84
Morbidity of Psoriasis and psoriatic arthritis in the Repu­blic of Bashkortostan in 2012—2022. Russian Journal of Preventive Medi­cine. 2024;(7):38-45
New viral infe­ctions — new challenges. Russian Journal of Preventive Medi­cine. 2024;(7):114-119
Epidemiological features of lary­ngeal papi­llomatosis in adults in Moscow. Russian Bulletin of Otorhinolaryngology. 2024;(3):4-10
The prevalence and risk factors of intracranial non-traumatic hemo­rrhage in newborns. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):26-30
Leading trends in breast cancer inci­dence in the Repu­blic of Crimea. P.A. Herzen Journal of Onco­logy. 2024;(4):42-47
Prevalence of diabetic reti­nopathy asse­ssed using two-field mydriatic fundus photography. Russian Annals of Ophthalmology. 2024;(4):60-67
Modern aspe­cts of etiopathogenesis, diagnosis and treatment of lipe­dema. Plastic Surgery and Aesthetic Medi­cine. 2024;(3):86-92

BACKGROUND

Infection caused by M. genitalium (MG) is classified as sexually transmitted infections (STIs). At the same time, MG infection is not currently registered at the state level, in this connection data on its prevalence in countries around the world can only be obtained from scientific publications.

OBJECTIVE

To analyze the publications on the epidemiology of MG infection in countries around the world between 2017 and 2024.

MATERIAL AND METHODS

The search for publications of the PubMed database according to «Mycoplasma genitalium prevalence» keywords during the period from 1988 to 2024 (date of search — 14.08.2024) was performed. A total of 961 publications were found for this date; we analyzed a number of relevant publications (86 in total) on the prevalence of MG infection in the world from 2017 to 2024.

RESULTS

MG causes urethritis in men and reproductive tract damage in women. The prevalence of MG in countries around the world in general is not very high and amounts to 1—3.3% men and women in the total population. The indicator of MG infection prevalence among persons from «risk groups» (commercial sex workers, MSM), patients of STIs clinics with symptoms of urethritis, cervicitis, PID is significantly higher, reaching 20—45%. Risk factors for MG infection are young age, early sexual activity, «risky» sexual behavior (sexual promiscuity, neglect of barrier contraception, receptive anal sex), alcohol addiction, smoking, presence and pre-exposure prophylaxis of HIV infection, co-infection by other causative agents of STIs (e.g., C. trachomatis, N. gonorrhoeae), past history of STIs, abnormal vaginal microecology.

Keywords:

sexually transmitted infections
M.genitalium
pathogenesis
epidemiology
prevalence
risk factors
review

Authors:

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
The Russian National Research Medical University named after N.I. Pirogov

Frigo N.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
State Research Center — Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Negasheva E.S.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Gushchin A.E.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Dolya O.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
Peoples’ Friendship University of Russia

Kitaeva N.V.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology

Dmitriev G.A.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology;
Gabrichevsky Institute Of Epidemiology And Microbiology

Mardanly S.G.

CJSC ECOlab

Golousenko I.Yu.

Russian University of Medicine

Received:

14.10.2024

Accepted:

14.01.2025

List of references:

  1. Tully JG, Taylor-Robinson D, Cole RM, Rose DL. A newly discovered mycoplasma in the human urogenital tract. Lancet. 1981;1:1288-1291.
  2. Taylor-Robinson D, Tully JG, Furr PM, Cole RM, Rose DL, Hanna NF. Urogenital mycoplasma infections of man: a review with observations on a recently discovered mycoplasma. Isr J Med Sci. 1981;17:524-530. 
  3. Totten PA, Schwartz MA, Sjostrom KE, Kenny GE, Handsfield HH, Weiss JB. Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis. 2001;183:269-276. 
  4. Deguchi T, Maeda S. Mycoplasma genitalium: another important pathogen of nongonococcal urethritis. J Urol. 2002;167:1210-1217.
  5. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev. 2011;24:498-514. 
  6. Cohen CR, Manhart LE, Bukusi EA, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet. 2002;359:765-766. 
  7. Cohen CR, Mugo NR, Astete SG, et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect. 2005;81:463-466. 
  8. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015;61:418-426. 
  9. Horner PJ, Gilroy CB, Thomas BJ, Naidoo RO, Taylor-Robinson D. Association of Mycoplasma genitalium with acute non-gonococcal urethritis. Lancet. 1993;342:582-585. 
  10. Keane FE, Thomas BJ, Gilroy CB, Renton A, Taylor-Robinson D. The association of Chlamydia trachomatis and Mycoplasma genitalium with non-gonococcal urethritis: observations on heterosexual men and their female partners. Int J STD AIDS. 2000;11:435-439. 
  11. Gambini D, Decleva I, Lupica L, Ghislanzoni M, Cusini M, Alessi E. Mycoplasma genitalium in males with nongonococcal urethritis: prevalence and clinical efficacy of eradication. Sex Transm Dis. 2000;27:226-229. 
  12. Bjornelius E, Lidbrink P, Jensen JS. Mycoplasma genitalium in non-gonococcal urethritis — a study in Swedish male STD patients. Int J STD AIDS. 2000;11:292-296. 
  13. Johannisson G, Enstrom Y, Lowhagen GB, Nagy V, Ryberg K, Seeberg S, et al. Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden. Int J STD AIDS. 2000;11:324-326. 
  14. Maeda S, Tamaki M, Nakano M, Uno M, Deguchi T, Kawada Y. Detection of Mycoplasma genitalium in patients with urethritis. J Urol. 1998;159:405-407. 
  15. Deguchi T, Komeda H, Yasuda M, Tada K, Iwata H, Asano M, et al. Mycoplasma genitalium in non-gonococcal urethritis. Int J STD AIDS. 1995; 6:144-145. 
  16. Jensen JS, Cusini M, Gomberg M, Moi H, Wilson J, Unemo M. 2021 European guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022;36(5):641-650.  https://doi.org/10.1111/jdv.17972
  17. Kay Htaik, Lenka A Vodstrcil, Erica L Plummer, Amelia M Sfameni, Dorothy A Machalek, Lisa E Manhart, Catriona S Bradshaw. Systematic review and meta-analysis of the association between Mycoplasma genitalium and Pelvic inflammatory disease (PID). Clin Infect Dis. 2024 Jun 07:ciae295. Online ahead of print. https://doi.org/10.1093/cid/ciae295
  18. Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.  https://doi.org/10.15585/mmwr.rr7004a1
  19. Frenzer C, Egli-Gany D, Vallely LM, Vallely AJ, Low N. Adverse pregnancy and perinatal outcomes associated with Mycoplasma genitalium: systematic review and meta-analysis. Sex Transm Infect. 2022;98(3):222-227.  https://doi.org/10.1136/sextrans-2021-055352
  20. Vani Govender, Dhayendre Moodley, Megeshinee Naidoo, Cathy Connoly, Sinaye Ngcapu, Quarraisha Abdool Karim. Sexually transmitted infections in pregnancy and adverse pregnancy outcomes: A retrospective cohort study Int J Gynaecol Obstet. 2024 Jul;166(1):62-70. Epub 2024 Apr 04.  https://doi.org/10.1002/ijgo.15529
  21. Tully JG, Rose DL, Baseman JB, Dallo SF, Lazzell AL, Davis CP. Mycoplasma pneumoniae and Mycoplasma genitalium mixture in synovial fluid isolate. J. Clin Microbiol. 1995;33:1851-1855.
  22. Andersen B, Sokolowski I, Ostergaard L, Kjølseth Møller J, Olesen F, Jensen JS. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect. 2007;83:237-241. 
  23. Oakeshott P, Aghaizu A, Hay P, et al. Is Mycoplasma genitalium in women the “New Chlamydia?” A community-based prospective cohort study. Clin Infect Dis. 2010;51:1160-1166.
  24. Manhart LE, Holmes KK, Hughes JP, Houston LS, Totten PA. Mycoplasma genitalium among young adults in the United States: An emerging sexually transmitted infection. Am J Public Health. 2007;97:1118-1125.
  25. Sonnenberg P, Ison CA, Clifton S, et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16—44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int J Epidemiol. 2015;44:1982-1994.
  26. Sethi S, Singh G, Samanta P, Sharma M, et al. Mycoplasma genitalium: an emerging sexually transmitted pathogen. Indian J Med Res. 2012 Dec; 136(6):942-955. 
  27. Scott A, Weinstein AD, Stiles BG. A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium. Sexual Health. 2011;8:143-158. 
  28. Hancock EB, Manhart LE, Nelson SJ, Kerani R, Wroblewski JKH, Totten PA. Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women. Sex Transm Dis. 2010; in press. https://doi.org/10.1097/OLQ.0b013e3181e8087e
  29. Cohen CR, Nosek M, Meier A, Astete SG, Iverson-Cabral S, Mugo NR, et al. Mycoplasma genitalium infection and persistence in acohort of female sex workers in Nairobi, Kenya. Sex Transm Dis. 2007;34:274-279. 
  30. Kapiga SH, Sam NE, Mlay J, Aboud S, Ballard RC, Shao JF, et al. The epidemiology of HIV-1 infection in northern Tanzania: results from a community-based study. AIDS Care. 2006;18:379-387.  https://doi.org/10.1080/09540120500465012
  31. Manhart LE, Mostad SB, Baeten JM, Astete SG, Mandilaya K, Totten PA. High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix. J Infect Dis. 2008;197:733-736.  https://doi.org/10.1086/526501
  32. Napierala Mavedzenge S, Weiss HA. Association of Mycoplasma genitalium and HIV infection: a systematic review and metaanalysis. AIDS. 2009; 23:611-620.  https://doi.org/10.1097/QAD.0b013e328323da3e
  33. Soni S, Alexander S, Verlander N, Saunders P, Richardson D, Fisher M, et al. The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex Transm Infect. 2010;86:21-24.  https://doi.org/10.1136/sti.2009.038190
  34. Jensen JS. Mycoplasma genitalium infections. Dan Med Bull. 2006;53:1-27. 
  35. Lukas Baumann, Manuel Cina, Dianne Egli-Gany, Myrofora Goutaki, Florian S Halbeisen, Gian-Reto Lohrer, Hammad Ali, Pippa Scott, Nicola Low. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm Infect. 2018 Jun;94(4):255-262.  https://doi.org/10.1136/sextrans-2017-053384
  36. Hilmarsdóttir I, Arnardóttir EM, Jóhannesdóttir ER, Valsdóttir F, Golparian D, Hadad R, Vigfússon HB, Unemo M, et al. Prevalence of Mycoplasma genitalium and Antibiotic Resistance-Associated Mutations in Patients at a Sexually Transmitted Infection Clinic in Iceland, and Comparison of the S-DiaMGTV and Aptima Mycoplasma genitalium Assays for Diagnosis. J Clin Microbiol. 2020 Aug 24;58(9):e01084-20.  https://doi.org/10.1128/JCM.01084-20
  37. Begnis R, Bouscaren N, Raffray L, Terrier CSP, Andry F, Boukerrou M, Koumar Y, Moiton MP, Gerardin P, Bertolotti A. Prevalence and risk factors of Mycoplasma genitalium infection in patients attending a sexually transmitted infection clinic in Reunion Island: a cross-sectional study (2017-2018). BMC Infect Dis. 2021 May 26;21(1):482.  https://doi.org/10.1186/s12879-021-06193-6
  38. Mulligan V, Lynagh Y, Clarke S, Unemo M, Crowley B, et al. Prevalence, Macrolide Resistance, and Fluoroquinolone Resistance in Mycoplasma genitalium in Men Who Have Sex With Men Attending an Sexually Transmitted Disease Clinic in Dublin, Ireland in 2017-2018. Sex Transm Dis. 2019 Apr;46(4):e35-e37.  https://doi.org/10.1097/OLQ.0000000000000940
  39. Madsen AMR, Thorsteinsson K, Lebech AM, et al. Prevalence and significance of Mycoplasma genitalium in women living with HIV in Denmark BMC Res Notes. 2017 Sep 07;10(1):468.  https://doi.org/10.1186/s13104-017-2776-5
  40. Desdorf R, Andersen NM, Chen M, et al. Mycoplasma genitalium prevalence and macrolide resistance-associated mutations and coinfection with Chlamydia trachomatis in Southern Jutland, Denmark. APMIS. 2021 Dec;129(12): 706-710.  https://doi.org/10.1111/apm.13174
  41. Unemo M, Salado-Rasmussen K, Hansen M, Olsen AO, Falk M, Golparian D, Aasterød M, Ringlander J, Nilsson CS, Sundqvist M, Schønning K, Moi H, Westh H, Jensen JS, et al. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. Clin Microbiol Infect. 2018 May;24(5):533-539.  https://doi.org/10.1016/j.cmi.2017.09.006
  42. Skjælaaen K, Nesvold H, Brekke M, Sare M, Landaas ET, Mdala I, Olsen AO, Vallersnes OM. Sexually transmitted infections among patients attending a sexual assault centre: a cohort study from Oslo, Norway. BMJ Open. 2022 Dec 1;12(12):e064934. https://doi.org/10.1136/bmjopen-2022-064934
  43. Björnelius E, Magnusson C, Jensen JS, et al. Mycoplasma genitalium macrolide resistance in Stockholm, Sweden. Sex Transm Infect. 2017 May; 93(3):167-168.  https://doi.org/10.1136/sextrans-2016-052688
  44. Rebecca Kertes, Sinja Kristiansen, Annika Johnsson, Ola Forslund, Carina Bjartling. Prevalence of Mycoplasma genitalium and macrolide resistance in rectal and urine samples among men who have sex with men in Sweden Sex Transm Infect. 2024 Aug 01:sextrans-2023-056044. Online ahead of print. https://doi.org/10.1136/sextrans-2023-056044
  45. Libois A, Hallin M, Crucitti T, Delforge M, De Wit S, et al. Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study. PLoS One. 2018 Apr 26;13(4):e0196217. https://doi.org/10.1371/journal.pone.0196217
  46. Hokynar K, Hiltunen-Back E, Mannonen L, Puolakkainen M, et al. Prevalence of ycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland. Int J STD AIDS. 2018 Aug;29(9): 904-907.  https://doi.org/10.1177/0956462418764482
  47. Korhonen S, Hokynar K, Eriksson T, Natunen K, Paavonen J, Lehtinen M, Puolakkainen M. The Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in Finland. Pathogens. 2019 Dec 01;8(4):276.  https://doi.org/10.3390/pathogens8040276
  48. Tjagur S, Mändar R, Punab M, et al. Prevalence of Mycoplasma genitalium and other sexually transmitted infections causing urethritis among high-risk heterosexual male patients in Estonia. Infect Dis (Lond). 2018 Feb;50(2): 133-139.  https://doi.org/10.1080/23744235.2017.1366044
  49. Nijhuis RHT, Duinsbergen RG, Pol A, Godschalk PCR, et al. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands. Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):591-595.  https://doi.org/10.1007/s10096-020-04061-w
  50. Hetem DJ, Kuizenga Wessel S, Bruisten SM, Braam JF, van Rooijen MS, Vergunst CE, Nijhuis RH, Berns M, Brand JM, van Dam AP. High prevalence and resistance rates of Mycoplasma genitalium among patients visiting two sexually transmitted infection clinics in the Netherlands. Int J STD AIDS. 2021 Aug;32(9):837-844.  https://doi.org/10.1177/0956462421999287
  51. Yusuf E, Mertens K, van Lisdonk N, Houwen C, Thai KTD, et al. Epidemiology of Mycoplasma genitalium and Trichomonas vaginalis in the primary health care setting in the Netherlands. Epidemiol Infect. 2023 May 5;151:e79.  https://doi.org/10.1017/S095026882300064X
  52. Perry MD, Jones S, Bertram A, de Salazar A, Barrientos-Durán A, Schiettekatte G, Lewinski M, Arcenas R, Hansra A, Njoya M, García F, et al. The prevalence of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) at testing centers in Belgium, Germany, Spain, and the UK using the cobas TV/MG molecular assay. Eur J Clin Microbiol Infect Dis. 2023 Jan;42(1):43-52.  https://doi.org/10.1007/s10096-022-04521-5
  53. Broad CE, Furegato M, Harrison MA, Pond MJ, Tan N, Okala S, Fuller SS, Harding-Esch EM, Sadiq ST, et al. High prevalence of coinfection of azithromycin-resistant Mycoplasma genitalium with other STIs: a prospective observational study of London-based symptomatic and STI-contact clinic attendees. Sex Transm Infect. 2021 Feb;97(1):63-68.  https://doi.org/10.1136/sextrans-2019-054356
  54. Pereyre S, Laurier Nadalié C, Bébéar C; investigator group. Pereyre S, et al. Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases. Clin Microbiol Infect. 2017 Feb;23(2):122.e1-122.e7.  https://doi.org/10.1016/j.cmi.2016.10.028
  55. Herms F, Poizeau F, Anyfantakis V, Bonhomme P, Chaine-Sidibé B, Louison JB, Berçot B, Bagot M, Fouéré S; Groupe infectiologie dermatologique et infections sexuellement transmissibles (GrIDIST) de la Société française de dermatologie (SFD). Mycoplasma genitalium screening in a specialized French unit: A retrospective study. Ann Dermatol Venereol. 2022 Sep;149(3): 165-168.  https://doi.org/10.1016/j.annder.2021.08.004
  56. Brin C, Palich R, Godefroy N, Simon A, Robert J, Bébéar C, Sougakoff W, Agher R, Caumes E, Monsel G. Clinical, epidemiological and therapeutic characteristics of Mycoplasma genitalium infection in a French STI center. Infect Dis Now. 2022 Feb;52(1):13-17.  https://doi.org/10.1016/j.idnow.2021.09.003
  57. Asenjo A, Kusters JG, Severs TT, Alós JI, et al. Mycoplasma genitalium in Spain: prevalence of genital infection and frequency of resistance to macrolides. Enferm Infecc Microbiol Clin (Engl Ed). 2018 Mar;36(3):169-171.  https://doi.org/10.1016/j.eimc.2017.01.006
  58. Treviño M, Rodríguez-Velasco M, Manso T, Cea M. Mycoplasma genitalium in Primary Care: Prevalence and azithromycin resistance in Santiago de Compostela Health Care Area. Rev Esp Quimioter. 2021 Oct;34(5):496-499.  https://doi.org/10.37201/req/052.2021
  59. Maldonado-Barrueco A, Rodríguez-Ayala M, Grandioso-Vas D, García-Clemente P, Guedez-López GV, García-Rodríguez J, Quiles-Melero I, et al. Epidemiology and prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium in a tertiary hospital from Madrid, Spain. Rev Esp Quimioter. 2023 Jun;36(3):310-313.  https://doi.org/10.37201/req/123.2022
  60. Leli C, Mencacci A, Latino MA, Clerici P, Rassu M, Perito S, Castronari R, Pistoni E, Luciano E, De Maria D, Morazzoni C, Pascarella M, Bozza S, Sensini A, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: An Italian observational multicentre study. J Microbiol Immunol Infect. 2018 Apr;51(2):220-225.  https://doi.org/10.1016/j.jmii.2017.05.004
  61. Angela A, Raffaele DP, Federica R, Adriana M, Luigi S, Luigi R, et al. Multi-year prevalence and macrolide resistance of Mycoplasma genitalium in clinical samples from a southern Italian hospital. Eur J Clin Microbiol Infect Dis. 2021 Apr;40(4):893-895.  https://doi.org/10.1007/s10096-020-04068-3
  62. Klavs I, Milavec M, Berlot L, Kustec T, Grgič-Vitek M, Lavtar D, Zaletel M, Golle A, Duh D, Žohar Čretnik T, et al. Prevalence of sexually transmitted infections with Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis: findings from the National Survey of Sexual Lifestyles, Attitudes and Health, Slovenia, 2016 to 2017. Euro Surveill. 2022 Apr;27(14):2100284. https://doi.org/10.2807/1560-7917.ES.2022.27.14.2100284
  63. Kadylak D, Czarny J, Nowicki RJ, Sokołowska-Wojdyło MJ. The Prevalence of Sexually Transmitted Infections among Male Patients at a Dermato-Venereology Outpatient Clinic in Gdansk, Poland: Findings from a Single-Center Study. Clin Med. 2024 Jun 26;13(13):3736. https://doi.org/10.3390/jcm13133736
  64. Ljubin-Sternak S, Meštrović T, Kolarić B, Jarža-Davila N, Marijan T, Vraneš J. Assessing the Need for Routine Screening for Mycoplasma genitalium in the Low-risk Female Population: A Prevalence and Co-infection Study on Women from Croatia. Int J Prev Med. 2017 Jul 04;8:51.  https://doi.org/10.4103/ijpvm.IJPVM_309_16
  65. Chra P, Papaparaskevas J, Papadogeorgaki E, Panos G, Leontsinidis M, Arsenis G, Tsakris A. Germs. Prevalence of Mycoplasma genitalium and other sexually-transmitted pathogens among high-risk individuals in Greece. BMC Infectious Diseases. 2018 Mar 01;8(1):12-20.  https://doi.org/10.18683/germs.2018.1128
  66. Zhang XH, Zhao PZ, Ke WJ, Wang LY, Tso LS, Chen ZY, Liao YY, Liang CM, Chen HR, Ren XQ, Huang JM, Ong JJ, Yang F, Yang LG, et al. Prevalence and correlates of Mycoplasma genitalium infection among patients attending a sexually transmitted infection clinic in Guangdong, China: a cross-sectional study. BMC Infect Dis. 2021 Jul 5;21(1):649.  https://doi.org/10.1186/s12879-021-06349-4
  67. Han Y, Yin YP, Liu JW, Chen K, Zhu BY, Zhou K, Shi MQ, Xu WQ, Jhaveri TA, Chen XS. Rectal Mycoplasma genitalium in Patients Attending Sexually Transmitted Disease Clinics in China: An Infection That Cannot Be Ignored. Infect Drug Resist. 2021 Jun 30;14:2509-2515. https://doi.org/10.2147/IDR.S314775
  68. Tu W, Li YY, Kuang YQ, Xie RH, Dong XQ, Zhang D, Ma YL, Zhang WY, Lu L. High prevalence of sexually transmitted infections and risk factors among HIV-positive individuals in Yunnan, China. Eur J Med Res. 2022 Jan 13;27(1):9.  https://doi.org/10.1186/s40001-022-00635-w
  69. Wang L, Li Z, Wan C, Tian X, Liu H, Li Y. Prevalence of Mycoplasma genitalium infection with antimicrobial resistance mutations among gay sex workers in China. Int J STD AIDS. 2023 Jul;34(8):518-524.  https://doi.org/10.1177/09564624231160676
  70. Zhang Z, Zong X, Bai H, Fan L, Li T, Liu Z. Prevalence of Mycoplasma genitalium and Chlamydia trachomatis in Chinese female with lower reproductive tract infection: a multicenter epidemiological survey. BMC Infect Dis. 2023 Jan 5;23(1):2.  https://doi.org/10.1186/s12879-022-07975-2
  71. Tsai MJ, Sun HY, Su LH, Lin KY, Liu WD, Huang YS, Chen GJ, Su YC, Liu WC, Chang SY, Hung CC. Mycoplasma genitalium infection and resistance-associated mutations to macrolides and fluoroquinolones among high-risk patients in Taiwan. Microbiol Immunol Infect. 2024 Aug;57(4):629-637.  https://doi.org/10.1016/j.jmii.2024.05.004
  72. Ando N, Mizushima D, Takano M, Mitobe M, Miyake H, Yokoyama K, Sadamasu K, Aoki T, Watanabe K, Uemura H, Yanagawa Y, Gatanaga H, Oka S. High prevalence of circulating dual-class resistant Mycoplasma genitalium in asymptomatic MSM in Tokyo, Japan. JAC Antimicrob Resist. 2021 Jun 30;3(2):dlab091. https://doi.org/10.1093/jacamr/dlab091
  73. Biswal D, Gupta S, Sethi S, Singh S, Khanna N, Dhawan B. Macrolide and fluoroquinolone resistance associated mutations in Mycoplasma genitalium in men who have sex with men attending STI clinic: A pilot study from India. Indian J Dermatol Venereol Leprol. 2024 May 25:1-4.  https://doi.org/10.25259/IJDVL_933_2023
  74. Lam PPH, Nguyen NH, Nguyen TTT, Trinh NB, Luong BA. Mycoplasma genitalium prevalence, co-infection and macrolide resistance-associated mutations in Southern Vietnam. Infez Med. 2024 Jun 1;32(2):222-230.  https://doi.org/10.53854/liim-3202-10
  75. Güralp O, Bostancı A, Özerkman Başaran E, Schild-Suhren M, Kaya B. Evaluation of the prevalence of sexually transmitted bacterial pathogens in Northern Cyprus by nucleic acid amplification tests, and investigation of the relationship between these pathogens and cervicitis. Turk J Obstet Gynecol. 2019 Dec;16(4):242-248.  https://doi.org/10.4274/tjod.galenos.2019.80269
  76. Kirkoyun Uysal H, Koksal MO, Sarsar K, Ilktac M, Isik Z, Akgun Karapinar DB, Demirci M, Ongen B, Buyukoren A, Kadioglu A, Yurtsever E, Agacfidan A. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium among Patients with Urogenital Symptoms in Istanbul. Healthcare (Basel). 2023 Mar 23;11(7):930.  https://doi.org/10.3390/healthcare11070930
  77. Tamar Gottesman, Orit Yossepowitch, Zmira Samra, Shoshana Rosenberg, Michael Dan. Prevalence of Mycoplasma genitalium in men with urethritis and in high risk asymptomatic males in Tel Aviv: a prospective study. Int J STD AIDS. 2017 Feb;28(2):127-132.  https://doi.org/10.1177/0956462416630675
  78. Getman D, Jiang A, O’Donnell M, Cohen S. Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States. J Clin Microbiol. 2016 Sep;54(9):2278-2283. https://doi.org/10.1128/JCM.01053-16
  79. Seña AC, Lee JY, Schwebke J, Philip SS, Wiesenfeld HC, Rompalo AM, Cook RL, Hobbs MM. A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States. Clin Infect Dis. 2018 Jun 18;67(1):73-79.  https://doi.org/10.1093/cid/ciy025
  80. Dionne-Odom J, Geisler WM, Aaron KJ, Waites KB, Westfall AO, Van Der Pol B, Xiao L, et al. High Prevalence of Multidrug-Resistant Mycoplasma genitalium in Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Alabama. Clin Infect Dis. 2018 Feb 10;66(5):796-798.  https://doi.org/10.1093/cid/cix853
  81. Allan-Blitz LT, Mokany E, Campeau S, Wee R, Shannon C, Klausner JD, et al. Prevalence of Mycoplasma genitalium and Azithromycin-resistant Infections Among Remnant Clinical Specimens, Los Angeles. Sex Transm Dis. 2018 Sep;45(9):632-635.  https://doi.org/10.1097/OLQ.0000000000000829
  82. Gaydos CA, Manhart LE, Taylor SN, et al. Molecular testing for Mycoplasma genitalium in the United States: results from the AMES prospective multicenter clinical study. J Clin Microbiol. 2019;57(11):e01125-19.  https://doi.org/10.1128/JCM.01125-19
  83. Lillis RA, Martin DH, Nsuami MJ, et al. Mycoplasma genitalium Infections in Women Attending a Sexually Transmitted Disease Clinic in New Orleans. Clin Infect Dis. 2019 Jul 18;69(3):459-465.  https://doi.org/10.1093/cid/ciy922
  84. Manhart LE, Gaydos CA, Taylor SN. Characteristics of Mycoplasma genitalium urogenital infections in a diverse patient sample from the United States: results from the Aptima Mycoplasma genitalium Evaluation Study (AMES). J Clin Microbiol. 2020;58(7): without pages. https://doi.org/10.1128/JCM.00165-20
  85. Khosropour CM, Jensen JS, Soge OO, Leipertz G, Unutzer A, Pascual R, Barbee LA, Dombrowski JC, Golden MR, Manhart LE. High Prevalence of Vaginal and Rectal Mycoplasma genitalium Macrolide Resistance Among Female Sexually Transmitted Disease Clinic Patients in Seattle, Washington. Sex Transm Dis. 2020 May;47(5):321-325.  https://doi.org/10.1097/OLQ.0000000000001148
  86. Elizabeth A Torrone, Deanna Kruszon-Moran, Christi Philips, Monica R Morris, Katherine E Bowden, John Papp, Laura H Bachmann, Hillard Weinstock, Ellen N Kersh. Prevalence of Urogenital Mycoplasma genitalium Infection, United States, 2017 to 2018. Sex Transm Dis. 2021 Nov 01; 48(11):e160-e162. https://doi.org/10.1097/OLQ.0000000000001394
  87. Lisa E Manhart, Gina Leipertz, Olusegun O Soge, Stephen J Jordan, Candice McNeil, Preeti Pathela, Hilary Reno, Karen Wendel, Anika Parker, William M Geisler, Damon Getman, Matthew R Golden; MyGeniUS Study Team Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions. Clin Infect Dis. 2023 Nov 17; 77(10):1449-1459. https://doi.org/10.1093/cid/ciad405
  88. Menezes ME, Silver EJ, Goldstein DY, Collins-Ogle MD, Fox AS, Coupey SM, et al. Prevalence and Factors Associated With Mycoplasma genitalium Infection in At-Risk Female Adolescents in Bronx County, New York. Sex Transm Dis. 2023 Oct 01;50(10):635-641.  https://doi.org/10.1097/OLQ.0000000000001840
  89. Muhan Hu, Jaclyn Paige Souder, Akila Subramaniam, Barbara Van Der Pol, Li Xiao, Kanupriya Gupta, Jodie Dionne-Odom, William M Geisler. Prevalence of Mycoplasma genitalium infection and macrolide resistance in pregnant women receiving prenatal care. Int J Gynaecol Obstet. 2023 Jan;160(1): 341-344.  https://doi.org/10.1002/ijgo.14443
  90. Dionne Gesink, C Sarai Racey, Christine Seah, Sandra Zittermann, Leo Mitterni, Jerry Juzkiw, Heather Jamieson, Jane Greer, Sudesh Singh, Jørgen Skov Jensen, Vanessa Allen. Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance. Can Fam Physician. 2016 Feb; 62(2):e96-101. 
  91. Jennifer Gratrix, Sabrina Plitt, LeeAnn Turnbull, Petra Smyczek, Judith Brandley, Ron Scarrott, Prenilla Naidu, Penny Parker, Brenda Blore, Amy Bull, Sandy Shokoples, Lindsay Bertholet, Irene Martin, Max Chernesky Ron Read, Ameeta Singh. Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis. BMJ Open. 2017 Jul 10;7(7):e016300. https://doi.org/10.1136/bmjopen-2017-016300
  92. Nidhi R Parmar, Linda Mushanski, Tasker Wanlin. Aurora Lepe, Amanda Lang, Jessica Minion, Jo-Anne R Dillon. High Prevalence of Macrolide and Fluoroquinolone Resistance-Mediating Mutations in Mycoplasma genitalium-Positive Urine Specimens From Saskatchewan. Sex Transm Dis. 2021 Sep 01;48(9):680-684.  https://doi.org/10.1097/OLQ.0000000000001402
  93. Lê AS, Labbé AC, Fourmigue A, Dvorakova M, Cox J, Fortin C, Martin I, Grace D, Hart T, Moore D, Lambert G. Engage Study Team Mycoplasma genitalium infection among gay, bisexual and other men who have sex with men in Montreal, Canada. Can Commun Dis Rep. 2023 Nov 01;49(11-12): 477-486.  https://doi.org/10.14745/ccdr.v49i1112a03
  94. Brian A Mondeja, Nadia M Rodríguez, Orestes Blanco, Carmen Fernández, Jørgen S Jensen. Mycoplasma genitalium infections in Cuba: surveillance of urogenital syndromes, 2014-2015. Int J STD AIDS. 2018 Sep;29(10): 994-998.  https://doi.org/10.1177/0956462418767186
  95. Shipitsyna E, Kularatne R, Golparian D, Müller EE, Vargas SK, Hadad R, Padovese V, Hancali A, Alvarez CS, Oumzil H, Camey E, Blondeel K, Toskin I, Unemo M. Mycoplasma genitalium prevalence, antimicrobial resistance-associated mutations, and coinfections with non-viral sexually transmitted infections in high-risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019-2021. Front Microbiol. 2023 Feb 22;14:1130762. https://doi.org/10.3389/fmicb.2023.1130762
  96. Miranda AE, Gaspar PC, Schörner MA, Barazzetti FH, Dias GB, Bigolin A, Pascom ARP, Barreira D, Bazzo ML. Brazilian Surveillance for STIs in Pregnant Women Group Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium and risk factors among pregnant women in Brazil: Results from the national molecular diagnosis implementation project. Int J Gynaecol Obstet. 2024 Jul; 166(1):71-79.  https://doi.org/10.1002/ijgo.15447
  97. Bazzo ML, Machado HM, Martins JM, Schörner MA, Buss K, Barazzetti FH, Gaspar PC, Bigolin A, Benzaken A, de Carvalho SVF, Andrade LDF, Ferreira WA, Figueiroa F, Fontana RM, da Silva MFCR, Silva RJC, Aires Junior LF, Neves LAS, Miranda AE, Network BG. Aetiological molecular identification of sexually transmitted infections that cause urethral discharge syndrome and genital ulcer disease in Brazilian men: a nationwide study. Sex Transm Infect. 2024 Apr 18;100(3):133-137.  https://doi.org/10.1136/sextrans-2023-055950
  98. Mahlape P Mahlangu, Etienne E Müller, Johanna M E Venter, Dumisile V Maseko, Ranmini S Kularatne. The Prevalence of Mycoplasma genitalium and Association With Human Immunodeficiency Virus Infection in Symptomatic Patients, Johannesburg, South Africa, 2007-2014. Sex Transm Dis. 2019 Jun;46(6):395-399.  https://doi.org/10.1097/OLQ.0000000000000984
  99. Ong JJ, Magooa MP, Chikandiwa A, Kelly H, Didelot MN, Muller EE, Maseko V, Segondy M, Delany-Moretlwe S, Kularatne R, Mayaud P; HIV in Africa Research Partnership Study Group Ong JJ. Prevalence and Antimicrobial Resistance of Mycoplasma genitalium Infection Among Women Living With Human Immunodeficiency Virus in South Africa: A Prospective Cohort Study. Clin Infect Dis. 2019 Aug 16;69(5):873-876.  https://doi.org/10.1093/cid/ciz045
  100. Carolyn P Smullin, Hunter Green, Remco Peters, Dorothy Nyemba, Yamkela Qayiya, Landon Myer, Jeffrey Klausner, Dvora Joseph Davey. Prevalence and incidence of Mycoplasma genitalium in a cohort of HIV-infected and HIV-uninfected pregnant women in Cape Town, South Africa. Sex Transm Infect. 2020 Nov;96(7):501-508.  https://doi.org/10.1136/sextrans-2019-054255
  101. Harryparsad R, Meyer B, Taku O, Serrano M, Chen PL, Gao X, Williamson AL, Mehou-Loko C, d’Hellencourt FL, Smit J, Strauss J, Nanda K, Ahmed K, Beksinska M, Buck G, Morrison C, Deese J, Masson L. Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives. PLoS One. 2023 Nov 10;18(11):e0294285. https://doi.org/10.1371/journal.pone.0294285
  102. Crowell TA, Lawlor J, Lombardi K, Nowak RG, Hardick J, Odeyemi S, Kokogho A, Malia J, Stewart C, Robb ML, Baral SD, Adebajo S, Charurat ME, Ake JA, Peel SA, Gaydos CA; TRUST/RV368 Study Group. Crowell TA, Anorectal and Urogenital Mycoplasma genitalium in Nigerian Men Who Have Sex With Men and Transgender Women: Prevalence, Incidence, and Association With HIV. Sex Transm Dis. 2020 Mar;47(3):202-206.  https://doi.org/10.1097/OLQ.0000000000001105
  103. Ezeanya-Bakpa CC, Agbakoba NR, Enweani-Nwokelo IB, Oguejiofor CB. Phylogeny-based identification of Mycoplasma genitalium in a Nigerian population of apparently healthy sexually active female students. Pan Afr Med J. 2022 Jan 25;41:71. 
  104. Balkus JE, Manhart LE, Jensen JS, Anzala O, Kimani J, Schwebke J, Shafi J, Rivers C, Kabare E, McClelland RS. Mycoplasma genitalium Infection in Kenyan and US Women. Sex Transm Dis. 2018 Aug;45(8):514-521.  https://doi.org/10.1097/OLQ.0000000000000799
  105. Lokken EM, Kabare E, Oyaro B, Nyaigero M, Kinuthia J, Jaoko W, Mandaliya K, McClelland RS, Manhart LE. A prospective preconception cohort study of the association between Mycoplasma genitalium and fecundability in Kenyan women trying to conceive. Hum Reprod. 2023 Oct 03;38(10): 2020-2027. https://doi.org/10.1093/humrep/dead172
  106. Melendez JH, Hardick J, Onzia A, Yu T, Kyambadde P, Parkes-Ratanshi R, Nakku-Joloba E, Kiragga A, Manabe YC, Hamill MM. Retrospective Analysis of Ugandan Men with Urethritis Reveals Mycoplasma genitalium and Associated Macrolide Resistance. Microbiol Spectr. 2022 Apr 27;10(2): e0230421. https://doi.org/10.1128/spectrum.02304-21
  107. Lindman J, Djalo MA, Biai A, Månsson F, Golparian D, Esbjörnsson J, Jansson M, Medstrand P, Unemo M, Norrgren H; Sweden Guinea-Bissau Cohort Research (SWEGUB CORE) group; SWEGUB CORE group. Prevalence of sexually transmitted infections and associated risk factors among female sex workers in Guinea-Bissau. Sex Transm Infect. 2024 Aug 13:sextrans-2023-056015. https://doi.org/10.1136/sextrans-2023-056015
  108. Manjate A, Sergon G, Kenga D, Golparian D, Tyulenev Y, Loquilha O, Mausse F, Guschin A, Langa JC, Passanduca A, Sacarlal J, Unemo M. Prevalence of sexually transmitted infections (STIs), associations with sociodemographic and behavioural factors, and assessment of the syndromic management of vaginal discharge in women with urogenital complaints in Mozambique. Front Reprod Health. 2024 Apr 18;6:1323926. https://doi.org/10.3389/frph.2024.1323926
  109. De Baetselier I, Vuylsteke B, Cuylaerts V, Cuer B, Yaya I, Mensah E, Dah E, Anoma C, Koné A, Diandé S, Dagnra A, Fayé-Ketté H, Yeo A, Smet H, Van den Bossche D, Keita BD, Spire B, Laurent C, Crucitti T; CohMSM-PrEP Study Group. Mycoplasma genitalium and Antimicrobial Resistance Among a Cohort of West African Men Who Have Sex With Men Using Preexposure Prophylaxis (CohMSM-PrEP ANRS 12369-Expertise France Study). Open Forum Infect Dis. 2022 Nov 9;9(11):ofac615. https://doi.org/10.1093/ofid/ofac615
  110. Jary A, Teguete I, Sidibé Y, Kodio A, Dolo O, Burrel S, Boutolleau D, Beauvais-Remigereau L, Sayon S, Kampo M, Traoré FT, Sylla M, Achenbach C, Murphy R, Berçot B, Bébéar C, Calvez V, Marcelin AG, Maiga AI. Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali. Int J Infect Dis. 2021 Jul;108:610-616.  https://doi.org/10.1016/j.ijid.2021.06.024
  111. Couldwell DL, Jalocon D, Power M, Jeoffreys NJ, Chen SC, Lewis DA. Mycoplasma genitalium: high prevalence of resistance to macrolides and frequent anorectal infection in men who have sex with men in western Sydney. Sex Transm Infect. 2018 Sep;94(6):406-410.  https://doi.org/10.1136/sextrans-2017-053480
  112. Trevis T, Gossé M, Santarossa N, Tabrizi S, Russell D, McBride WJ. Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance. PLoS One. 2018 Aug 28;13(8):e0202428. https://doi.org/10.1371/journal.pone.0202428
  113. Bradley I, Varma R, Knight V, Iliakis D, McNally L, Jalocon D, Jeoffreys N, Chen S, McNulty A. Prevalence of rectal Mycoplasma genitalium and macrolide resistance in men who have sex with men attending Sydney Sexual Health Centre. Sex Health. 2020 Apr;17(2):114-120.  https://doi.org/10.1071/SH18221
  114. Cheung C, Bourne C, Varma R. Mycoplasma genitalium: test positivity in  syndromic presentations and clinicians’ adherence with treatment guidelines at Sydney Sexual Health Centre. Int J STD AIDS. 2021 Oct;32(12):1174-1177. https://doi.org/10.1177/09564624211022583
  115. Ong JJ, Ruan L, Lim AG, Bradshaw CS, Taylor-Robinson D, Unemo M, Horner PJ, Vickerman P, Zhang LE. Impact of screening on the prevalence and incidence of Mycoplasma genitalium and its macrolide resistance in men who have sex with men living in Australia: A mathematical model. EClinicalMedicine. 2021 Mar 03;33:100779. https://doi.org/10.1016/j.eclinm.2021.100779
  116. Taylor-Robinson D, Renton A, Jensen JS, Ison CA, Filatova E, Dmitriev G, Akovbian V. Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis. Int J STD AIDS. 2009 Apr;20(4):234-237.  https://doi.org/10.1258/ijsa.2008.008298
  117. Shipitsyna E, Zolotoverkhaya E, Dohn B, Benkovich A, Savicheva A, Sokolovsky E, Jensen JS, Domeika M, Unemo M. First evaluation of polymerase chain reaction assays used for diagnosis of Mycoplasma genitalium in Russia. J Eur Acad Dermatol Venereol. 2009 Oct;23(10):1164-1172. https://doi.org/10.1111/j.1468-3083.2009.03276.x
  118. Khryanin A, Reshetnikov O. Detection rates of Mycoplasma genitalium and Chlamydia trachomatis infections in Novosibirsk, Siberia, in 2010-2011. Sex Transm Infect. 2012 Oct;88(6):469.  https://doi.org/10.1136/sextrans-2012-050596
  119. Berle LM, Firsova N, Kalashnik A, Protasova VM, Ponomareva ZV, Gubernickaya SV, Kudrina TI, Haaheim H, Hjelmevoll SO, Skogen V. Chlamydia trachomatis, Mycoplasma genitalium and Ureaplasma urealyticum in clinical and non-clinical settings, Arkhangelsk Oblast, Russia. Int J STD AIDS. 2012 Nov;23(11):781-784.  https://doi.org/10.1258/ijsa.2012.011410
  120. Romanova IV, Kisina VI, Khayrullina GA, Frigo NV, Zhukova OV, Gushchin AE. The prevalence and type of mutations of in dermatovenereological patients from the Moscow region for 2014‒2018. Russian Journal of Clinical Dermatology and Venereology. 2020;19(1):7-12. (In Russ.). https://doi.org/10.17116/klinderma2020190117
  121. Bernier A, Rumyantseva T, Reques L, Volkova N, Kyburz Y, Maximov O, Derrienic E, Guschin A, Bouscaillou J, Luhmann N, Pataut D. HIV and other sexually transmitted infections among female sex workers in Moscow (Russia): prevalence and associated risk factors. Sex Transm Infect. 2020 Dec;96(8):601-607.  https://doi.org/10.1136/sextrans-2019-054299
  122. Shipitsyna E, Khusnutdinova T, Budilovskaya O, et al. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia. Eur J Clin Microbiol Infect Dis. 2020;39(7):1221-1230. https://doi.org/10.1007/s10096-020-03831-w

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.